Rezolve AI Limited Warrants (RZLVW)
Valuation Overview•Is Rezolve AI Limited Warrants Overvalued or Undervalued?
The market is pricing the stock in line with historical averages, assuming steady-state growth.
Fragile underlying quality score of 27/100; weak margins or elevated debt leverage warrant caution.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
RZLVW struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company is facing top-line contraction (-63.6% 3Y CAGR) paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (-1024.1%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $12.6M | +29.5% | -63.6% | — | — | |
| EBITDA | -$61.7M | — | -55.2% | — | — | |
| Net Income | -$115.7M | -461.7% | -66.0% | — | — | |
| EPS (Diluted) | $-0.48 | -12010.0% | — | — | — | |
| Free Cash Flow | -$10.0M | -70.3% | -7.0% | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 95.5% | -129.7% | -83.4% | -83.4% |
| Operating Margin | -1024.1% | -61464.6% | -46337.1% | -46337.1% |
| Net Margin | -1540.1% | -69755.4% | -52558.1% | -52558.1% |
| FCF Margin | -215.3% | -15630.1% | -11854.2% | -11854.2% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q4'25Latest | $-0.16 | $-0.50 | -209.7% | ||
| Q4'24 | — | $-0.38 | — | ||
| Q2'24 | — | $-0.00 | — | ||
| Q4'23 | — | $-0.04 | — | ||
| Q2'23 | — | $0.00 | — | ||
| Q4'22 | — | $0.01 | — | ||
| Q2'22 | — | $-0.02 | — | ||
| Q1'70 | — | — | — |
Total return is +21.5% (1Y), outperforming the benchmark by +0.7%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -13.2% | -20.5% | — |
| 1Y | +21.5% | +0.7% | — |
| 3YCAGR | +76.0% | +58.6% | — |
| 5YCAGR | +40.4% | +29.8% | — |
| 10YCAGR | +18.5% | +5.2% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Rezolve AI Limited Warrants (RZLVW) valuation, health, and returns.
Rezolve AI Limited Warrants valuation is being assessed using available models.
Valuation anchors are currently not available.
Rezolve AI Limited Warrants displays weak financial health with a composite quality score of 27/100, supported by a Altman Z-Score of -41.5 (distress zone), Piotroski F-Score of 5/9.
Rezolve AI Limited Warrants returns capital via buybacks instead of dividends, carrying a 1.8% buyback yield and reducing outstanding shares by -45.0% in the last 12 months.
Rezolve AI Limited Warrants's current growth trajectory is Accelerating. The company achieved +29.5% 1Y revenue growth and -12010.0% 1Y EPS growth, compared to its 3Y revenue CAGR of -63.6%.
Wall Street consensus is Hold based on 0 analysts. The consensus price target represents a N/A change from current levels.
Investment risks for Rezolve AI Limited Warrants include: -73.7% 1-year max drawdown, high beta (1.36x market volatility), elevated distress risk. Volatility risk is characterized by a beta of 1.36x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.